Literature DB >> 12787832

Lidocaine attenuates muscarinic receptor-mediated inhibition of adenylyl cyclase in airway smooth muscle.

Motonari Yunoki1, Tsutomu Nakahara, Akiko Mitani, Takeshi Maruko, Yuko Kubota, Kenji Sakamoto, Kunio Ishii.   

Abstract

We examined how lidocaine affects muscarinic receptor-mediated inhibition of adenylyl cyclase in bovine tracheal smooth muscles. Lidocaine (100 microM) augmented the relaxant responses to forskolin in the bovine tracheal smooth muscle contracted with methacholine (0.3 microM). On the other hand, lidocaine failed to affect the relaxant effects of forskolin on the histamine (100 microM)- and KCl (40 mM)-contracted preparations. Lidocaine (100 microM) enhanced both basal and forskolin-stimulated cAMP accumulation in the presence of methacholine (0.3 microM). However, in the absence of methacholine, neither basal nor forskolin-stimulated cAMP accumulation was affected by lidocaine. Similar phenomenon was observed when the bovine tracheal smooth muscles were treated with methoctramine (0.03 microM). In radioligand binding experiments, lidocaine inhibited [3H]N-methyl scopolamine binding to cloned human muscarinic receptors (M(1)-M(5)) expressed in Chinese hamster ovary cells. These results suggest that lidocaine prevents muscarinic receptor-mediated signaling pathway and thereby reverses inhibition of adenylyl cyclase by methacholine in bovine tracheal smooth muscle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787832     DOI: 10.1016/s0014-2999(03)01755-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Effects of levobupivacaine on isolated rat tracheal smooth muscle.

Authors:  Hung-Chi Chang; Shin-Yan Chen; Yu-Feng Huang; Feng-Lin Liu; Yih-Giun Cherng; Hsing-Won Wang
Journal:  J Anesth       Date:  2015-05-21       Impact factor: 2.078

2.  Effects of lidocaine on rat's isolated tracheal smooth muscle.

Authors:  Chuan-Hsiang Kao; Yueng-Hsiang Chu; Hsing-Won Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-08-28       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.